Rituximab (International)
In the US, Rituximab (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Evan's Syndrome, Focal Segmental Glomerulosclerosis, Follicular Lymphoma, Granulomatosis with Polyangiitis, Immune Thrombocytopenia, Mantle Cell Lymphoma, Microscopic Polyangiitis, Non-Hodgkin's Lymphoma, Pemphigus Vulgaris, Rheumatoid Arthritis and Thrombocytopenia.
US matches:
- Rituximab
- Rituximab and hyaluronidase human, recombinant
- Rituximab-abbs
- Rituximab-arrx
- Rituximab-pvvr
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XC02
CAS registry number (Chemical Abstracts Service)
0174722-31-7
Chemical Formula
C6416-H9874-N1688-O1987-S44
Molecular Weight
143860
Therapeutic Categories
Immunosuppressant
Antineoplastic agent
Microtubule inhibitor
Biological response modifier, BRM
Anti-CD20 monoclonal antibody
Chemical Name
Immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gama 1-chain anti-human antigen CD 20), disulfide wit human-mouse monoclonal IDEC-C2B8 kapa-chain, dimer (WHO)
Foreign Names
- Rituximabum (Latin)
- Rituximab (German)
- Rituximab (French)
- Rituximab (Spanish)
Generic Names
- Rituximab (OS: BAN, DCF, USAN)
- Rituximab (Genetical Recombination) (OS: JAN)
- IDEC 102 (IDEC) (IS)
- IDEC C2B8 (IDEC) (IS)
Brand Names
- Acellbia
Biocad, Georgia - Blitzima
Celltrion, Estonia; Celltrion, Slovenia; Celltrion Healthcare, Sweden; Celltrion Healthcare Hungary, Poland - Mab Thera
Roche Registration, Slovenia - MabThera
F. Hoffmann-La Roche, Macedonia; F. Hoffmann-La Roche LTD, Serbia; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche D.O.O., Serbia; Roche Pharmaceutical, China; Roche Products, United Kingdom; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Uruguay, Uruguay - Mabthera
Roche, Germany; Roche, Pakistan; Roche Products, Australia; Roche Registration, Netherlands - MabThera 100mg
Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - MabThera 10mg/ml
Roche, Israel - MabThera 1400mg
Haemato Pharm, Austria; Orifarm, Austria; Roche, Israel; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - Mabthera 1400mg/11.7ml
Roche, Luxembourg - Mabthera 1600mg/13.4ml
Roche, Luxembourg - MabThera 500mg
Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - MabThera SC
Roche, Brazil; Roche Products, Australia - Novex
Elea, Argentina - Reditux
Complex Therapeutics, Chile; Dr Reddy's Lab, Myanmar; Dr. Reddy's Laboratories, Vietnam - Rilast
Hetero, Georgia - Ritemvia
Celltrion, Estonia; Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Orion Pharma, Denmark; Orion Pharma, Finland; Orion Pharma, Sweden - Ritemvia 500mg
Celltrion Healthcare, Austria - Rituxan
Genentech, United States; Hoffmann-La Roche, Canada; Zenyaku Kogyo, Japan - Rituxan Hycela [+ Hyaluronidase]
Genentech, United States - Rituximab
Baxter, New Zealand - Rituzena
Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Celltrion Healthcare, Sweden - Rixanthon
Sandoz, Latvia - Rixathon
Sandoz, Estonia; Sandoz, United Kingdom; Sandoz, Netherlands; Sandoz, Norway; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece - Rixathon 100mg
Hexal, Germany - Rixathon 100mg/10ml
Sandoz, Switzerland - Rixathon 500mg
Hexal, Germany - Rixathon 500mg/50ml
Sandoz, Switzerland - Riximyo
Sandoz, Estonia; Sandoz, Latvia; Sandoz, Netherlands; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece - Truxima
Biogaran, France; Celltrion, Georgia; Celltrion Healthcare, Lithuania; Celltrion Healthcare, Romania; Celltrion Healthcare Hungary Kft., Greece; Egis, Georgia; Kern Pharma, Spain; Mundipharma, Belgium; Mundipharma, Germany; Mundipharma Pharmaceuticals, Netherlands; Napp Pharmaceuticals, United Kingdom; Orion Pharma, Sweden - Truxima 100mg
Mundipharma, Luxembourg - Truxima 100mg/10ml
iQone, Switzerland - Truxima 500mg
Mundipharma, Luxembourg - Truxima 500mg/50ml
iQone, Switzerland - Tuxella
Celltrion, Estonia - Zytux
AryoGen, Georgia
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
DCF | Dénomination Commune Francaise |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The drugclasses.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.